Replies to post #354922 on Innovation Pharmaceuticals Inc (IPIX)

[TradingPro]

Antibiotics are not lucrative enough, which is why B drop pursuing a PHIII trial give the crazy FDA requirements. Wouldn’t have been a a good ROI. The industry buyouts also died for the same reasons on promising antibiotics. Best to pursue B for other areas.

[leavetheguntakethecannolis]

Is that not one of the major reasons why Leo went to Russia?

One of the most brilliant moves to date IMO.